Horizon Quantum Announces Second Quarter 2026 Financial Results
Second Quarter 2026 Financial and Business Highlights (all figures approximate and presented in USD):
- Beryllium, Horizon’s object-oriented programming language, became available to early access users at the end of Q2 2026.
- A strategic collaboration with Quantum Machines has been announced, which includes the joint development of embedded calibration technologies.
-
Ember-1, Horizon’s
Singapore -based testbed system, became available to first users. -
Cash received from exercise of warrants improves financial runway. As of
August 3, 2026 cash balances have been fortified by proceeds of$28.7 million from the exercise of approximately 2.5 million publicly traded warrants (Nasdaq: HQWWW) (the “Public Warrants”). During Q2 2026, 2.4 million of these were exercised for gross proceeds of$27.5 million , which combined with existing cash, resulted in total cash and cash equivalents at the end of Q2 2026 of$113.3 million , a net increase of$16.7 million from$96.6 million at the end of the fiscal quarter endedMarch 31, 2026 (“Q1 2026”). -
Operating loss for Q2 2026 on an as-reported basis of
$7.2 million compared to$2.7 million for the second fiscal quarter endedJune 30, 2025 (“Q2 2025”). -
Net loss for Q2 2026 on an as-reported basis of
$115.2 million , or$2.20 per ordinary share, compared to a loss of$2.9 million in Q2 2025, or$0.07 per ordinary share in Q2 of 2025. The Q2 2026 quarter result included a$108.3 million non-cash loss from the remeasurement of warrant-related derivative liabilities driven by an increase in the Company’s share price. -
Adjusted EBITDA was a loss of
$5.5 million in Q2 2026 as compared to a loss of$2.1 million in Q2 2025.
CEO Commentary
“During the second quarter of 2026, we reached important milestones with Beryllium, an object-oriented quantum programming language that we believe will allow developers to build increasingly sophisticated quantum applications and begin to abstract away the subtleties of quantum mechanics from the work necessary to realize quantum advantage. More recently, we also announced a strategic collaboration with Quantum Machines, which aims to further our technical capabilities in calibration,” said
He continued, “I am also pleased to share that
Operational Highlights
Beryllium
Beryllium is Horizon Quantum’s object-oriented quantum programming language. It aims to enable developers to construct quantum programs in a way that resembles modern classical software engineering. It introduces advanced control flow structures and familiar programming constructs, including classes, functions, and libraries to quantum programming, allowing developers to define reusable quantum components analogous to those used in today’s classical programming languages.
By providing a high level of abstraction, Beryllium is designed to let developers focus on algorithmic intent rather than implementation mechanics and to make quantum software development more accessible and efficient.
Beryllium is currently the highest level of abstraction available within Triple Alpha. It can be compiled down to Helium, Triple Alpha’s BASIC–like language, and Hydrogen, its assembly language, as well as targeted quantum hardware.
-
Beryllium saw its release to early access users at the end of the second quarter of 2026, following its initial preview in
December 2025 at the annual Quantum to Business (Q2B) trade show. -
During the first half of 2026,
Horizon Quantum extended and finalized the initial release of the Beryllium language, enhancing its core capabilities. The Company also improved the performance and stability of the Beryllium layer in its compiler. -
Beryllium libraries:
Horizon Quantum has begun building Beryllium libraries that implement standard algorithmic building blocks. With these libraries,Horizon Quantum aims to enable developers, even those without deep quantum expertise, to build complex quantum algorithms with less code.
Hardware Collaborators
By tightly integrating its software infrastructure with a variety of hardware platforms,
-
Quantum Machines – strategic collaboration on calibration: In
July 2026 ,Horizon Quantum announced a strategic collaboration with Quantum Machines, a leading provider of advanced quantum control solutions, to enhance Ember-1 uptime by leveraging Quantum Machines' control platform and engineering expertise. This collaboration is intended to result in an embedded calibration framework that enables lightweight calibration routines to execute as part of normal system operation, thereby increasing uptime by reducing reliance on lengthy full-system calibration cycles.
Testbed
-
Testbed opens to first users: Ember-1, Horizon Quantum’s initial testbed system located at its
Singapore headquarters and running sinceDecember 2025 , has been opened to select first users. By enabling tighter hardware-software integration, the testbed environment provides efficient execution, extended capabilities, and faster iteration by accelerating the feedback loop. - Triple Alpha on Ember-1 supports real-time execution of complete programs, eliminating the need for post-selected execution. The environment provides pulse- and gate-level access, supporting a broad range of quantum operations, experiments, and workflows.
-
Second testbed system to be located at Horizon Quantum’s European headquarters: In
June 2026 ,Horizon Quantum announced it would locate a 256-qubit trapped-ion system, anticipated to be one of the most advanced commercial quantum systems in the world, inDublin, Ireland . This testbed adds a second, technologically distinct hardware modality, and with its expected qubit count and high gate fidelities, the system may be capable of solving some challenging computational problems.
Second Quarter 2026 Financial Results
All results presented as approximate and in USD.
-
Cash generated from the exercise of Public Warrants improved the Company’s financial runway. As of
August 3, 2026 approximately 2.5 million Public Warrants, representing 79% of the Public Warrants outstanding at the close of the business combination, had been exercised. The exercise of these Public Warrants has generated gross proceeds to the Company of approximately$28.7 million to date. As of the end of Q2 2026, a total of approximately 2.4 million Public Warrants had been exercised generating$27.5 million in gross proceeds, which, combined with existing cash, resulted in a total cash balance of$113.3 million as ofJune 30, 2026 . This represents a net increase of$16.7 million from$96.6 million as of the end of Q1 2026. -
Total operating expenses for Q2 2026 were
$7.2 million compared to$2.8 million for Q2 2025. -
Research and development (R&D) expenses for Q2 2026 were
$2.6 million compared to$1.2 million for Q2 2025, representing an increase of 117%. When excluding share-based compensation and non-recurring compensation adjustments from each period of$0.7 million and$0.3 million , respectively, the period-over-period increase in R&D expenses was 100% and was primarily attributable to increases in headcount and to a lesser extent costs from the setup of the hardware testbed. -
Sales and marketing expenses for Q2 2026 were
$0.4 million , up 51% period-over-period compared to$0.2 million for Q2 2025. When excluding share-based compensation and non-recurring compensation adjustments from each period of$0.08 million and$0.07 million , respectively, the period-over-period increase in sales and marketing expenses was 63% and was primarily attributable to increased trade show activity and industry engagement. -
General and administrative (G&A) expenses for Q2 2026 were
$3.8 million compared to$1.1 million for Q2 2025, representing an increase of 236%. Excluding share-based compensation, non-recurring compensation adjustments and one-time business combination expenses of$1.5 million and$0.3 million from Q2 2026 and Q2 2025, respectively, G&A expenses increased 191% period over period. The period-over-period increase in G&A expenses was primarily due to increases in headcount, and other operating expenses associated with transitioning to a public company. -
Operating loss for Q2 2026 was
$7.2 million compared to$2.7 million for Q2 2025, representing an increase of$4.4 million . The widening of the loss was primarily due to increases in expenses associated with transitioning to a public company, increases in research and development headcount, and related operational support costs as compared to the prior-year period. -
Net loss for Q2 2026 was
$115.2 million , or$2.20 per ordinary share, compared to a net loss of$2.9 million , or$0.07 per ordinary share, in Q2 2025.-
The Q2 2026 result included a
$108.3 million non-cash loss from the remeasurement of warrant-related derivative liabilities. The increase in the trading price of Horizon Quantum’s Class A ordinary shares during Q2 2026 increased the fair value of these liabilities, resulting in the accounting charge. This charge did not affect the Company’s cash balance. By contrast, the voluntary exercise of Public Warrants during Q2 2026 generated cash proceeds and increased share capital. -
All warrants of
Horizon Quantum that remain outstanding will continue to be remeasured at fair value each fiscal quarter. Accordingly, future movements in the trading price of Horizon Quantum’s Class A ordinary shares could result in additional non-cash gains or losses. -
Because these fair-value adjustments can create substantial volatility in reported earnings without affecting underlying operating performance or cash flow, management also evaluates results on an Adjusted EBITDA basis, a non-GAAP measure. Adjusted EBITDA excludes changes in the fair value of derivative liabilities as well as share-based compensation, and non-recurring expenses associated with the business combination. On this basis, the company recorded an Adjusted EBITDA loss of
$5.5 million for Q2 2026 compared with an Adjusted EBITDA loss of$2.1 million in Q2 2025.
-
The Q2 2026 result included a
Conference Call Information
As previously announced, the company will hold a conference call to discuss its second quarter on
Non-GAAP Financial Measures
To supplement Horizon Quantum’s condensed financial statements presented in accordance with
About
Founded in 2018 by Dr.
Note to Investors Regarding Forward-Looking Statements
This press release includes forward-looking statements. The expectations, estimates, and projections of the businesses of
|
Condensed consolidated balance sheet (Unaudited) |
||||||||
|
|
|
|
|
|
||||
|
(In US$, unless otherwise stated) |
|
|
2026 |
|
|
|
2025 |
|
|
ASSETS |
|
|
|
|
||||
|
Current assets |
|
|
|
|
||||
|
Cash and cash equivalents |
|
$ |
113,254,440 |
|
|
$ |
222,939 |
|
|
Prepaid and other current assets |
|
|
6,868,373 |
|
|
|
746,372 |
|
|
Total current assets |
|
|
120,122,813 |
|
|
|
969,311 |
|
|
|
|
|
|
|
||||
|
Property and equipment, net |
|
|
3,489,535 |
|
|
|
3,204,829 |
|
|
Intangible assets, net |
|
|
20,392 |
|
|
|
22,566 |
|
|
Right-of-use assets |
|
|
361,307 |
|
|
|
459,982 |
|
|
Other non-current assets |
|
|
51,716 |
|
|
|
175,115 |
|
|
TOTAL ASSETS |
|
$ |
124,045,763 |
|
|
$ |
4,831,803 |
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
||||
|
Current liabilities |
|
|
|
|
||||
|
Derivative liabilities - SAFE |
|
$ |
- |
|
|
$ |
6,406,878 |
|
|
Other payables |
|
|
3,224,136 |
|
|
|
2,602,604 |
|
|
Operating lease liabilities |
|
|
325,126 |
|
|
|
396,025 |
|
|
Total current liabilities |
|
|
3,549,262 |
|
|
|
9,405,507 |
|
|
|
|
|
|
|
||||
|
Derivative liabilities - warrants |
|
|
76,778,574 |
|
|
|
- |
|
|
Operating lease liabilities, non-current |
|
|
42,393 |
|
|
|
88,921 |
|
|
TOTAL LIABILITIES |
|
$ |
80,370,229 |
|
|
$ |
9,494,428 |
|
|
|
|
|
|
|
||||
|
STOCKHOLDERS’ EQUITY |
|
|
|
|
||||
|
Seed Preferred Shares, 2,500,000 authorized; 2,500,000 issued and outstanding as of |
|
$ |
- |
|
|
$ |
839,602 |
|
|
Seed Plus Preferred Shares, 2,936,828 authorized; 2,936,828 issued and outstanding as of |
|
|
- |
|
|
|
2,349,212 |
|
|
Series A Preferred Shares, 2,586,522 authorized; 2,586,522 issued and outstanding as of |
|
|
- |
|
|
|
18,100,000 |
|
|
Ordinary Shares, 8,000,000 authorized; 8,000,000 issued and outstanding as of |
|
|
- |
|
|
|
3,649 |
|
|
Ordinary Class A Shares, 34,227,495 authorized, 34,227,495 issued and outstanding as of |
|
|
187,124,075 |
|
|
|
- |
|
|
Ordinary Class |
|
|
40,110 |
|
|
|
- |
|
|
Additional paid-in capital |
|
|
8,997,535 |
|
|
|
7,417,778 |
|
|
Equity proceeds receivable |
|
|
(343,862 |
) |
|
|
- |
|
|
Accumulated deficit |
|
|
(152,439,504 |
) |
|
|
(33,573,537 |
) |
|
Accumulated other comprehensive income |
|
|
297,180 |
|
|
|
200,671 |
|
|
TOTAL STOCKHOLDERS’ EQUITY |
|
$ |
43,675,534 |
|
|
$ |
(4,662,625 |
) |
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
$ |
124,045,763 |
|
|
$ |
4,831,803 |
|
|
Note: All results presented prior to the closing of the business combination on |
||||||||
|
Condensed consolidated statement of operations and comprehensive loss (Unaudited) |
|||||||||||||||
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
(In US$, except share amount and per share data) |
|
2026 |
|
|
|
2025 |
|
|
|
2026 |
|
|
|
2025 |
|
|
Revenue |
$ |
- |
|
$ |
38,462 |
|
|
$ |
- |
|
$ |
38,462 |
|
||
|
|
|
|
|
|
|
|
|
||||||||
|
Operating Expenses: |
|
|
|
|
|
|
|
||||||||
|
Research and development |
|
2,614,022 |
|
|
|
1,206,612 |
|
|
|
4,742,435 |
|
|
|
4,527,603 |
|
|
Selling and marketing |
|
375,989 |
|
|
|
248,716 |
|
|
|
834,952 |
|
|
|
576,665 |
|
|
General and administrative |
|
3,849,526 |
|
|
|
1,146,373 |
|
|
|
7,451,257 |
|
|
|
2,047,525 |
|
|
Depreciation and amortization |
|
335,966 |
|
|
|
180,787 |
|
|
|
646,233 |
|
|
|
349,836 |
|
|
Total operating expenses |
|
7,175,504 |
|
|
|
2,782,488 |
|
|
|
13,674,878 |
|
|
|
7,501,629 |
|
|
Loss from operations |
|
(7,175,504 |
) |
|
|
(2,744,027 |
) |
|
|
(13,674,878 |
) |
|
|
(7,463,167 |
) |
|
|
|
|
|
|
|
|
|
||||||||
|
Other income and (expense): |
|
|
|
|
|
|
|
||||||||
|
Interest expense |
|
(2,694 |
) |
|
|
(2,320 |
) |
|
|
(5,686 |
) |
|
|
(4,830 |
) |
|
Other income |
|
487,055 |
|
|
|
16,943 |
|
|
|
530,443 |
|
|
|
49,730 |
|
|
Change in fair value of derivative liabilities |
|
(108,294,223 |
) |
|
|
- |
|
|
|
(105,317,692 |
) |
|
|
- |
|
|
Foreign exchange (loss) |
|
(241,982 |
) |
|
|
(172,909 |
) |
|
|
(318,912 |
) |
|
|
(306,927 |
) |
|
Income tax expense |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
Net loss |
$ |
(115,227,348 |
) |
|
$ |
(2,902,313 |
) |
|
$ |
(118,786,726 |
) |
|
$ |
(7,725,194 |
) |
|
Other comprehensive loss: |
|
|
|
|
|
|
|
||||||||
|
Foreign currency translation adjustment |
|
62,202 |
|
|
|
72,683 |
|
|
|
96,509 |
|
|
|
290,671 |
|
|
Total comprehensive loss |
$ |
(115,165,146 |
) |
|
$ |
(2,829,630 |
) |
|
$ |
(118,690,217 |
) |
|
$ |
(7,434,523 |
) |
|
|
|
|
|
|
|
|
|
||||||||
|
Basic and diluted weighted average ordinary shares outstanding, as recast |
|
52,367,347 |
|
|
|
39,015,950 |
|
|
|
46,630,787 |
|
|
|
39,015,950 |
|
|
Net (loss) income per ordinary share, basic and diluted, as recast |
$ |
(2.20 |
) |
|
$ |
(0.07 |
) |
|
$ |
(2.55 |
) |
|
$ |
(0.20 |
) |
|
Note: All results presented prior to the closing of the business combination on |
|||||||||||||||
|
Condensed consolidated statement of cashflow (Unaudited) |
|||||||
|
|
|
|
|||||
|
|
Six Months Ended
|
||||||
|
(In US$, unless otherwise stated) |
|
2026 |
|
|
2025 |
|
|
|
Cash flows from operating activities |
|
|
|||||
|
Loss for the period |
$ |
(118,786,726 |
) |
$ |
(7,725,194 |
) |
|
|
Adjustments to reconcile net loss to net cash used for operating activities: |
|
|
|||||
|
Depreciation |
|
644,059 |
|
|
349,035 |
|
|
|
Share based compensation |
|
1,878,363 |
|
|
3,387,475 |
|
|
|
Change in fair value of derivative liabilities |
|
105,317,692 |
|
|
- |
|
|
|
Unrealized foreign currency transaction (gain) loss |
|
85,088 |
|
|
629,163 |
|
|
|
Amortization |
|
2,174 |
|
|
801 |
|
|
|
Changes in operating assets and liabilities: |
|
- |
|
|
- |
|
|
|
Accounts receivable |
|
- |
|
|
270,824 |
|
|
|
Other payables |
|
1,890,795 |
|
|
(241,801 |
) |
|
|
Lease liability |
|
(212,283 |
) |
|
(131,790 |
) |
|
|
Prepaid expenses and other assets |
|
(102,350 |
) |
|
(189,219 |
) |
|
|
Net cash used in operating activities |
|
(9,283,188 |
) |
|
(3,650,706 |
) |
|
|
|
|
|
|||||
|
Cash flows from investing activities |
|
|
|||||
|
Purchase of property, equipment including construction in progress |
|
(5,521,276 |
) |
|
(297,706 |
) |
|
|
Purchase of intangible assets and trademarks |
|
- |
|
|
- |
|
|
|
Net cash used in investing activities |
|
(5,521,276 |
) |
|
(297,706 |
) |
|
|
|
|
|
|||||
|
Cash flows from financing activities |
|
|
|||||
|
Proceeds from issuance of SAFE notes |
|
2,500,000 |
|
|
- |
|
|
|
Proceeds from exercise of warrants |
|
27,186,518 |
|
|
- |
|
|
|
Proceeds from merger and PIPE transaction, net of transaction costs |
|
98,167,633 |
|
|
- |
|
|
|
Net cash provided by financing activities |
|
127,854,151 |
|
|
- |
|
|
|
Effect of exchange rate changes on cash |
|
(18,186 |
) |
|
(194,118 |
) |
|
|
Net increase (decrease) in cash and cash equivalents |
|
113,031,501 |
|
|
(4,142,530 |
) |
|
|
Cash and cash equivalents at beginning of period |
|
222,939 |
|
|
4,848,855 |
|
|
|
Cash and cash equivalents at end of period |
$ |
113,254,440 |
|
$ |
706,325 |
|
|
|
Supplemental disclosures of non-cash transactions: |
|
|
|||||
|
Initial recognition of warrant liabilities at close of the business combination |
$ |
20,526,410 |
|
|
- |
|
|
|
Initial recognition of net assets at close of the business combination |
$ |
2,458,713 |
|
|
- |
|
|
|
Conversion of SAFE liabilities into equity at close of the business combination |
$ |
11,183,077 |
|
|
- |
|
|
|
Issuance of shares to a service provider |
$ |
269,000 |
|
|
- |
|
|
|
Reclassification of warrant liabilities to equity upon exercise |
$ |
46,789,330 |
|
|
- |
|
|
|
Note: All results presented prior to the closing of the business combination on |
|||||||
|
Reconciliation of Non-GAAP Financial Measures |
|||||||||||||||
|
Below is a reconciliation of net loss (GAAP) to adjusted EBITDA: |
|||||||||||||||
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
(In US$, unless otherwise stated) |
|
2026 |
|
|
|
2025 |
|
|
|
2026 |
|
|
|
2025 |
|
|
Net loss (GAAP) |
$ |
(115,227,348 |
) |
|
$ |
(2,902,313 |
) |
|
$ |
(118,786,726 |
) |
|
$ |
(7,725,194 |
) |
|
Adjustments |
|
|
|
|
|
|
|
||||||||
|
Net interest (income) expense |
|
(477,253 |
) |
|
|
(12,805 |
) |
|
|
(512,778 |
) |
|
|
(42,915 |
) |
|
Depreciation and amortization expenses |
|
335,966 |
|
|
|
180,787 |
|
|
|
646,233 |
|
|
|
349,836 |
|
|
EBITDA |
|
(115,368,635 |
) |
|
|
(2,734,330 |
) |
|
|
(118,653,271 |
) |
|
|
(7,418,272 |
) |
|
Adjustments |
|
|
|
|
|
|
|
||||||||
|
Share based compensation within |
|
|
|
|
|
|
|
||||||||
|
Research and development |
|
436,808 |
|
|
|
261,285 |
|
|
|
676,982 |
|
|
|
2,778,608 |
|
|
Selling and marketing |
|
46,320 |
|
|
|
65,299 |
|
|
|
92,386 |
|
|
|
170,448 |
|
|
General and administrative |
|
509,959 |
|
|
|
130,294 |
|
|
|
839,994 |
|
|
|
437,675 |
|
|
Change in fair value of derivative liabilities |
|
108,294,223 |
|
|
|
- |
|
|
|
105,317,692 |
|
|
|
- |
|
|
Business combination and post-closing expenses* |
|
622,980 |
|
|
|
214,101 |
|
|
|
2,164,930 |
|
|
|
214,101 |
|
|
Adjusted EBITDA |
$ |
(5,458,343 |
) |
|
$ |
(2,063,351 |
) |
|
$ |
(9,561,286 |
) |
|
$ |
(3,817,439 |
) |
|
*Includes |
|||||||||||||||
|
Note: All results presented prior to the closing of the business combination on |
|||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260804772155/en/
Investor Contact
investors@horizonquantum.com
Media Contact
Yanina Blaclard
media@horizonquantum.com
Source: